Skip to content

Upsher-Smith launches methimazole tablets

MAPLE GROVE, Minn. – Upsher-Smith Laboratories announced the recent launch of methimazole tablets, USP, 5 mg and 10 mg. The methimazole tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according to IQVIA.

MAPLE GROVE, Minn. – Upsher-Smith Laboratories announced the recent launch of methimazole tablets, USP, 5 mg and

10 mg. The methimazole tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according to IQVIA. The Therapeutic Equivalence (TE) code for the product is AB, and the original Reference Listed Drug (RLD) was the brand Tapazole.

Latest

P&G to buy Thorne

P&G to buy Thorne

For P&G, the acquisition introduces a premium supplement and wellness platform, capitalizing on growing consumer interest in preventive health and personalized wellness.

Ahold Delhaize reiterates outlook after resilient Q2

Ahold Delhaize reiterates outlook after resilient Q2

In the United States, net sales increased 1.4% at constant exchange rates, while comparable sales excluding gasoline rose 0.8%. Results were pressured by lower egg prices, reduced SNAP benefits, and pharmacy pricing changes related to the Inflation Reduction Act.